Top Picks: Accredited Activities

Most Viewed

ASH 2020 Meeting Highlights in Acute Myeloid Leukemia

Ross Levine, MD; Harry P. Erba, MD, PhD; Eytan M. Stein, MD

Navigating the Changing Landscape in AML: Key Considerations in Treatment Delivery

Chetasi Talati, MD; Harry P. Erba, MD, PhD; Sandra E. Kurtin, PhD, ANP-C, AOCN

Recent Activities by Topic

  • e-Newsletter: A Case Study in Secondary AML: Best Practice for Treatment Selection - J. Lancet, MD - Posted 01/20
  • e-Newsletter: Is it possible to deliver liposomal daunorubicin and cytarabine on an outpatient basis? - E. Wang, MD - Posted 12/07
  • VIDEO FAQ: What are the key factors you must take into consideration in determining upfront treatment for patients with high-risk, secondary AML? - E. Wang, MD (2:47) - Posted 11/30 video
  • e-Newsletter: Expert Opinions on Common Clinical Challenges in AML - N. Daver, MD; J. Altman, MD; A. Perl, MD - Posted 10/14
  • e-Newsletter: Key Updates from ASCO 2020 and EHA 2020: Experts Discuss Data and Implications Important to Clinical Practice - N. Daver, MD; A. Perl, MD - Posted 10/07
  • VIDEO FAQ: New Advances in AML Discussion - N. Daver, MD; J. Altman, MD; A. Perl, MD(15:33) - Posted 07/10
  • Additional activities...

MediCom Oncology Links

Please visit these other members of the MediCom Oncology family of sites.

Managing MDS Managing Myeloma Managing MPN The Practical Oncologist Managing Lymphoma